147 related articles for article (PubMed ID: 27754869)
21. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan.
Warren HS; Jones AL; Freeman C; Bettadapura J; Parish CR
J Immunol; 2005 Jul; 175(1):207-12. PubMed ID: 15972650
[TBL] [Abstract][Full Text] [Related]
22. Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells.
De Maria A; Biassoni R; Fogli M; Rizzi M; Cantoni C; Costa P; Conte R; Mavilio D; Ensoli B; Cafaro A; Moretta A; Moretta L
Eur J Immunol; 2001 Dec; 31(12):3546-56. PubMed ID: 11745374
[TBL] [Abstract][Full Text] [Related]
23. Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30).
Mavoungou E; Bouyou-Akotet MK; Kremsner PG
Clin Exp Immunol; 2005 Feb; 139(2):287-96. PubMed ID: 15654827
[TBL] [Abstract][Full Text] [Related]
24. CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity.
Marcenaro E; Augugliaro R; Falco M; Castriconi R; Parolini S; Sivori S; Romeo E; Millo R; Moretta L; Bottino C; Moretta A
Eur J Immunol; 2003 Dec; 33(12):3367-76. PubMed ID: 14635045
[TBL] [Abstract][Full Text] [Related]
25. Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.
Tang Q; Grzywacz B; Wang H; Kataria N; Cao Q; Wagner JE; Blazar BR; Miller JS; Verneris MR
J Immunol; 2008 Oct; 181(7):4507-15. PubMed ID: 18802053
[TBL] [Abstract][Full Text] [Related]
26. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
[TBL] [Abstract][Full Text] [Related]
27. Natural Killer Cell Activation Receptor NKp30 Oligomerization Depends on Its
Skořepa O; Pazicky S; Kalousková B; Bláha J; Abreu C; Ječmen T; Rosůlek M; Fish A; Sedivy A; Harlos K; Dohnálek J; Skálová T; Vaněk O
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708305
[TBL] [Abstract][Full Text] [Related]
28. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.
Butler SE; Brog RA; Chang CH; Sentman CL; Huang YH; Ackerman ME
Cancer Immunol Immunother; 2022 Jan; 71(1):165-176. PubMed ID: 34046711
[TBL] [Abstract][Full Text] [Related]
29. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
[TBL] [Abstract][Full Text] [Related]
30. Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune response.
Frias M; Rivero-Juarez A; Gordon A; Camacho A; Cantisan S; Cuenca-Lopez F; Torre-Cisneros J; Peña J; Rivero A
PLoS One; 2015; 10(3):e0121019. PubMed ID: 25811634
[TBL] [Abstract][Full Text] [Related]
31. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
[TBL] [Abstract][Full Text] [Related]
32. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
Yang CM; Yoon JC; Park JH; Lee JM
PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
[TBL] [Abstract][Full Text] [Related]
34. The CD3ζ adaptor structure determines functional differences between human and mouse CD16 Fc receptor signaling.
Aguilar OA; Fong LK; Ishiyama K; DeGrado WF; Lanier LL
J Exp Med; 2022 May; 219(5):. PubMed ID: 35320345
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.
Bensussan A; Remtoula N; Sivori S; Bagot M; Moretta A; Marie-Cardine A
J Invest Dermatol; 2011 Apr; 131(4):969-76. PubMed ID: 21191411
[TBL] [Abstract][Full Text] [Related]
36. NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli.
Hollyoake M; Campbell RD; Aguado B
Mol Biol Evol; 2005 Aug; 22(8):1661-72. PubMed ID: 15872155
[TBL] [Abstract][Full Text] [Related]
37. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients.
Semeraro M; Rusakiewicz S; Minard-Colin V; Delahaye NF; Enot D; Vély F; Marabelle A; Papoular B; Piperoglou C; Ponzoni M; Perri P; Tchirkov A; Matta J; Lapierre V; Shekarian T; Valsesia-Wittmann S; Commo F; Prada N; Poirier-Colame V; Bressac B; Cotteret S; Brugieres L; Farace F; Chaput N; Kroemer G; Valteau-Couanet D; Zitvogel L
Sci Transl Med; 2015 Apr; 7(283):283ra55. PubMed ID: 25877893
[TBL] [Abstract][Full Text] [Related]
38. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
39. [The studies for activating and inhibitory receptors on natural killer cells in HIV/HCV co-infected patients].
Zhao P; Zhang X; Kang FB; Zhang XW; Zhang L; Tan WH; Chen WW; Zhao M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):182-4. PubMed ID: 21977586
[TBL] [Abstract][Full Text] [Related]
40. Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
Hershkovitz O; Jarahian M; Zilka A; Bar-Ilan A; Landau G; Jivov S; Tekoah Y; Glicklis R; Gallagher JT; Hoffmann SC; Zer H; Mandelboim O; Watzl C; Momburg F; Porgador A
Glycobiology; 2008 Jan; 18(1):28-41. PubMed ID: 18006589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
